tiprankstipranks
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ:ACRV
US Market
ACRV
Acrivon Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see ACRV full AI Analyst Report?

Acrivon Therapeutics, Inc. (ACRV) Income Statement

838 Followers

Acrivon Therapeutics, Inc. Income Statement

Last quarter (Q4 2025), Acrivon Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Acrivon Therapeutics, Inc.'s net income was $-18.98M. See Acrivon Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.36M$ -1.01M$ -536.00K$ 0.00$ 0.00
Operating Expenses
$ 82.76M$ 88.19M$ 66.70M$ 32.66M$ 16.18M
Depreciation and Amortization
$ 1.36M$ 1.01M$ 536.00K$ 364.00K$ 37.00K
EBITDA
$ -82.76M$ -79.55M$ -59.85M$ -32.29M$ -16.15M
Operating Income
$ -84.11M$ -89.20M$ -67.24M$ -32.66M$ -16.18M
Other Income/Expenses
$ 6.21M$ 8.64M$ 6.85M$ 1.49M$ -59.00K
Pretax Income
$ -77.91M$ -80.56M$ -60.39M$ -31.17M$ -16.24M
Net Income
$ -77.91M$ -80.56M$ -60.39M$ -31.17M$ -16.24M
Per Share Metrics
Basic EPS
$ -2.02$ -2.10$ -2.74$ -1.42$ -1.26
Diluted EPS
$ -2.02$ -2.10$ -2.74$ -1.42$ -1.26
Weighted Average Shares Outstanding
 38.51M 38.30M 22.08M 21.92M 12.91M
Weighted Average Shares Outstanding (Diluted)
 38.51M 38.30M 22.08M 21.92M 12.91M
Currency in USD

Acrivon Therapeutics, Inc. Earnings and Revenue History